Table of contents
Volume 92, Issue S1
Published online 3 June 2005 (S1-S31)
Top of page
Top of page
Foreword
Targeting key pathways in tumour growth and development FREE
R S Herbst
Br J Cancer 92: S1-S1; doi:10.1038/sj.bjc.6602601
Original Articles
The realisation of targeted antitumour therapy FREE
R Bicknell
Br J Cancer 92: S2-S5; doi:10.1038/sj.bjc.6602602
ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity FREE
A J Ryan and S R Wedge
Br J Cancer 92: S6-S13; doi:10.1038/sj.bjc.6602603
ZD6474 – clinical experience to date FREE
J V Heymach
Br J Cancer 92: S14-S20; doi:10.1038/sj.bjc.6602604
Role of novel targeted therapies in the clinic FREE
R S Herbst
Br J Cancer 92: S21-S27; doi:10.1038/sj.bjc.6602605
Targeted antitumour therapy – future perspectives FREE
M Ranson and G Jayson
Br J Cancer 92: S28-S31; doi:10.1038/sj.bjc.6602606
The published online date indicates the date that the issue is published online and is the first official publication date of the issue.
